Navegar por autor "Poveda López, Eva"

Lung cancer in patients living with HIV infection

2015- Castro Iglesias, Angeles; Pedreira Andrade, José Domingo; Marcos Rodríguez, Pedro Jorge; Poveda López, Eva; Rodríguez Osorio, Iria; [et al.]

Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control

2022-03-15- Poveda López, Eva; Tabernilla García, Andres; Fitzgerald, Wendy; Salgado Barreira, Angel; Grandal Fustes, Marta; [et al.]

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers

2014- Vázquez Rodríguez, Pilar; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; Poveda López, Eva [et al.]

Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak

2015- Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; Cañizares Castellanos, Angelina; Aguilera Guirao, Antonio; [et al.]

Multi-step inhibition against HIV lifecycle-underlying the

2014- Poveda López, Eva

News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference

2015- Poveda López, Eva; Morano Amado, Luis

Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.

2022-09- Álvarez Díaz, Hortensia; Rava, Marta; Martínez Reglero, Cristina; Portilla, Joaquín; Peraire, Joaquim; [et al.]

Resistencia a telaprevir

2013- Poveda López, Eva

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing

2014- Pertega Diaz, Sonia; Bou Arévalo, Germán; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; [et al.]

Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone

2019- Yendewa, G. A.; Sahr, F.; AGUILERA GUIRAO, ANTONIO; Lakoh, S.; Sesay, M.; [et al.]

Seroprevalence of Hepatitis C Virus Infection by Year of Birth in Spain: Any impact of the USA CDC Recommendation of HCV Testing among Persons Born during 1945-1965?

2013- Bou Arévalo, Germán; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; Cañizares Castellanos, Angelina; [et al.]

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: Implications for clinical practice

2019- Alvarez, M.; Casas, P.; De Salazar, A.; Chueca, N.; Guerrero-Beltran, C.; [et al.]

The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts

2015- Poveda López, Eva; Tabernilla García, Andres

Trends in the Seroprevalence of Hepatitis B and C in a Large Cohort of Patients Attending at a Reference Medical Area in Spain over the Last Five-Years

2013- Bou Arévalo, Germán; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; Cañizares Castellanos, Angelina; [et al.]

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years

2015- Pertega Diaz, Sonia; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; Cañizares Castellanos, Angelina; [et al.]

Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges

2022- Perez Gonzalez, Alexandre; Suárez-García, I.; Ocampo, A.; Poveda López, Eva

Update on hepatitis C virus resistance to direct-acting antiviral agents

2014- Castro Iglesias, Angeles; Mena de Cea, Alvaro; Poveda López, Eva

Repositorio digital RUNA

Navegar por autor "Poveda López, Eva"

Lung cancer in patients living with HIV infection ﻿

Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control ﻿

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers ﻿

Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak ﻿

Multi-step inhibition against HIV lifecycle-underlying the ﻿

News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference ﻿

Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort. ﻿

Resistencia a telaprevir ﻿

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing ﻿

Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone ﻿

Seroprevalence of Hepatitis C Virus Infection by Year of Birth in Spain: Any impact of the USA CDC Recommendation of HCV Testing among Persons Born during 1945-1965? ﻿

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: Implications for clinical practice ﻿

The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts ﻿

Trends in the Seroprevalence of Hepatitis B and C in a Large Cohort of Patients Attending at a Reference Medical Area in Spain over the Last Five-Years ﻿

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years ﻿

Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges ﻿

Update on hepatitis C virus resistance to direct-acting antiviral agents ﻿

Lung cancer in patients living with HIV infection

Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers

Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak

Multi-step inhibition against HIV lifecycle-underlying the

News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference

Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.

Resistencia a telaprevir

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing

Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone

Seroprevalence of Hepatitis C Virus Infection by Year of Birth in Spain: Any impact of the USA CDC Recommendation of HCV Testing among Persons Born during 1945-1965?

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: Implications for clinical practice

The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts

Trends in the Seroprevalence of Hepatitis B and C in a Large Cohort of Patients Attending at a Reference Medical Area in Spain over the Last Five-Years

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years

Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges

Update on hepatitis C virus resistance to direct-acting antiviral agents